Navigation Links
NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population
Date:7/23/2008

LAWRENCE, Mass., July 23 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced ongoing public access to current summary information derived from a registry of NxStage patients with end-stage renal-disease (ESRD) who undergo hemodialysis at home on a more frequent, or daily, basis as an alternative to the conventional regimen of therapy received three times a week at a dialysis center.

This unique, quantitative portrait of key characteristics of ESRD patients who have been receiving daily home hemodialysis, which includes correlation with survival and kidney transplant relative to that observed with conventional hemodialysis, reflects more than a thousand patient years of experience and more than one million treatments. This is believed to be the largest known database of home hemodialysis patients.

Key statistics from the registry, which are available on the NxStage web site (http://www.nxstage.com/chronic_renal_care/registry/), include the following:

-- Survival and transplant rates are notably higher among the NxStage patient population undergoing daily therapy vs. reported figures for conventional, less frequent dialysis treatment. NxStage patients on home daily hemodialysis experienced a better than 50% reduction in expected mortality compared to the overall U.S. hemodialysis patient population. This observed difference was statistically significant (P<0.0001).

-- Patients of varied size, age, vascular access type, and geographic location are participating in home daily hemodialysis, indicating its broad applicability.

-- 92% of the U.S. dia
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
2. NxStage Medical Provides Update on Medisystems Acquisition
3. NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd
4. Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical
5. NxStage Medical to Present at the Piper Jaffray Healthcare Conference on November 27, 2007
6. NxStage Medical Announces Needle Supply Agreement with DaVita
7. NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations
8. NxStage Medical to Present at William Blair Growth Stock Conference
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... 6 Myriant Technologies LLC ("Myri...ufacturer of renewable bio-chemicals, Uhde Corpor...ider Uhde GmbH, one of the world,s leading enginee...liance for the engineering, procurement & cons... plants based on renewable feedstocks. The execut...
(Date:11/6/2009)...Nov. 6 ,, 3Q09 Cor...Qutenza(TM) E.U. Marketing Authorization to Astell...in commercial readiness activities Expanded manag...arketing; and Director, Commercial Operations App...d Audit Committee chairman , Upcoming 2009 ...
(Date:11/6/2009)...Newswire-FirstCall/ - Oncolytics Biotech Inc. (TSX... today announced updated results from a Phase II s...arcomas metastatic to the lung in a poster present...y Society Meeting held in Miami Beach, Florida, fr...ntitled "A Phase II Study of Intravenous REOLYSIN ...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personalize...o take place on February 22-24, 2010 in Philadelph...ce we will highlight key issues in forming partner...experiences. , Minneapoli...rrowhead’s 2010 Personalized Medicine Partn...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
...ies Require Most Dramatic Changes , , NEW YORK, M...gles to manage rising risk, more than 40 percent o... of at least US$15 billion say that their companie... whole organization to survive the next decade, ac...ed by Deloitte Touche Tohmatsu (DTT). , , Reflect...
...s., March 9 Merrimack Pharmaceuticals, Inc., a pr...discovery and development of novel treatments for ...t Ulrik B. Nielsen has been promoted to Senior Vic...d (Tad) J. Stewart to Senior Vice President of Bus... played critical roles in building Merrimack int...
...ch 9 PURE Bioscience (Nasdaq: PURE ), creators ...timicrobial, today announced that John J. Carbone,... Dr. Carbone fills the vacancy left by the resigna...ogo: http://www.newscom.com/cgi-bin/prnh/2006011...EO and Chairman of PURE Bioscience, commented, "We...
Other Biology Technology:Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry 2Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry 3Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry 4Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry 5Merrimack Pharmaceuticals Promotes Ulrik B. Nielsen, Ph.D. to Chief Scientific Officer and Edward J. Stewart to Senior Vice President of Business Development 2PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors 2PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors 3PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors 4
(Date:11/6/2009)...ADELPHIA (November 06, 2009) The Monell Center an...ts of the Beijing International Meeting on Taste a...ation with the CAS, the meeting will be the first ...d in China. , Alan Leshner, Chief Executive Offi...cience and Executive Publisher of Science magazine...
(Date:11/4/2009)...ADELPHIA Although scientists are reluctant to off...ethod, evidence continues to grow about its protec...lished in Cancer Prevention Research , a journal ...hich suggests some reduction in oral cancer. , ...edicine in the Department of Thoracic/Head and Nec...
(Date:11/4/2009)...ouver, BC - Lowly bacteria, it turns out, hold the...ing plants around the world clean up toxic waste o...pecifically RDX, were invented back in World War I...ades. These high-energy compounds are often used ... version of TNT. , But with increased knowledg...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Genomic research will enable greener cleanup of military explosive test sites 21 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 11 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 2African American Office of Gay Concerns 28AAOGC 29 To Launch Status Is Everything HIV Testing Campaign 60175 1African American Office of Gay Concerns 28AAOGC 29 To Launch Status Is Everything HIV Testing Campaign 60175 2Anthem Blue Cross and Blue Shield in Missouri Earns NCQA Accreditation Status of Excellent 60173 1Anthem Blue Cross and Blue Shield in Missouri Earns NCQA Accreditation Status of Excellent 60173 2
...RGHCarnegie Mellon Universitys Chris T. Hendrickso...and Heather MacLean of the University of Toronto c...iminating dangerous carbon dioxide emissions that ...rchers found that farming and power generation are...issions per dollar output, according to research b...
...ease is available in German . , , Halle/S. The ...ogen could be lowered in future. Soil scientists a...(UFZ) have developed a new mathematical model whic...crobiological water treatment. Using the stable na...l, which is the most accurate to date, can for the...
...an Experts in the field of life in extreme environ...arctic Survey offices in Cambridge (UK) to officia...n for Research Activities on life in Extreme Envir...rging area of research in which Europe has conside...ch infrastructure. The science of such environment...
Other Biology News:Carnegie Mellon researchers to curb CO2 emissions 2New formula for combating the greenhouse gas nitrous oxide 2New formula for combating the greenhouse gas nitrous oxide 3New formula for combating the greenhouse gas nitrous oxide 4
Xylanase Fluorometric (Blue) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)
Goat Anti-Human p27 KIP 1 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Defender against cell death 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Goat Anti-Wnt-1 (G-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: